BG45 – 5 mg

Brand:
Cayman
CAS:
926259-99-6
Storage:
-20
UN-No:
Non-Hazardous - /

BG45 is an HDAC class I inhibitor with selectivity for HDAC3 (IC50 = 289 nM). It inhibits HDAC1, HDAC2, and HDAC6 with greatly reduced potency (IC50s = 2, 2.2, and >20 µM, respectively).{27757} At concentrations up to 50 mg/kg, BG45 alone or in combination with bortezomib has been shown to dose-dependently inhibit tumor growth in a mouse model of multiple myeloma.{27757}  

 

Out of stock

SKU: - Category:

Description

A selective inhibitor of HDAC3 (IC50 = 289 nM) that alone or in combination with bortezomib has been shown to dose-dependently inhibit tumor growth in a mouse model of multiple myeloma


Formal name: N-(2-aminophenyl)-2-pyrazinecarboxamide

Synonyms: 

Molecular weight: 214.2

CAS: 926259-99-6

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Deacetylases||Research Area|Epigenetics, Transcription, & Translation|Erasers|Histone Deacetylation